Clinical effects of Shenqi Fuzheng Injection in the neoadjuvant chemotherapy for local advanced breast cancer and the effects on T-lymphocyte subsets

Journal of Traditional Chinese Medicine

Volumn 28, Issue 1, 2008, Pages 34-38

  Dai, Zhijun ^a   Wang, Xijing ^a   Kang, Huafeng ^a   Ji, Zongzheng ^a   Liu, Lei ^a   Liu, Xiaoxu ^a   Song, Lingqin ^a   Min, Weili ^a   Ma, Xiaobin ^a  

^a XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

Breast cancer; Cellular immunity; Neoadjuvant chemotherapy; Shenqi Fuzheng Injection

Indexed keywords

ANTINEOPLASTIC AGENT; CHINESE DRUG; CYCLOPHOSPHAMIDE; EPIRUBICIN; FLUOROURACIL; GRANULOCYTE COLONY STIMULATING FACTOR; SHENQI FUZHENG; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ADVANCED CANCER; ANEMIA; ANTINEOPLASTIC ACTIVITY; ARTICLE; BONE MARROW SUPPRESSION; BREAST CANCER; CANCER ADJUVANT THERAPY; CELLULAR IMMUNITY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG POTENTIATION; GASTROINTESTINAL TOXICITY; HUMAN; HUMAN CELL; IMMUNOREGULATION; MAJOR CLINICAL STUDY; MULTIPLE CYCLE TREATMENT; NATURAL KILLER CELL; NEUTROPENIA; OUTCOME ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; T LYMPHOCYTE SUBPOPULATION; THROMBOCYTOPENIA;

ADULT; AGED; ANTINEOPLASTIC AGENTS; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; DRUGS, CHINESE HERBAL; FEMALE; HUMANS; MIDDLE AGED; NEOADJUVANT THERAPY; T-LYMPHOCYTE SUBSETS;

EID: 41749090706     PISSN: 02552922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Chinese source.
2. Sapunar F, Smith IE. Neoadjuvant chemotherapy for breast cancer. Ann Med 2000; 32: 43-50.
3. Chinese source.
4. Fisher B, Bryant J, Welmark N, et al. Effect of pre-operative chemotherapy on the outcome of woman with breast cancer:findings from NSABP-18. J Clin Oncol 1997; 15: 2488-2492.
5. Chinese source.
6. Chinese source.
7. Chinese source.
8. Chinese source.
9. Chinese source.
10. Chinese source.